Vaxon Biotech

Vaxon Biotech (Vaxon) is a privately held pharmaceutical company engaged in the development of novel therapeutic vaccines for the treatment of cancer. The company focuses on the development of the vaccines of lung, prostate, breast, renal, liver and colorectal cancer based on its proprietary technology of optimized cryptic peptides. Vaxon develops vaccines to treat existing cancers through stimulation of immune system to recognize and attack human cancer cells without affecting the normal cells. In addition, the company focuses extensively on the research and development operations and has developed a pipeline of tumor vaccines that cover major HLA-I to treat most cancer patients. Currently, the company is in development of four vaccines at the different stages of clinical trials for several life threatening cancer indications. The company is headquartered at Paris, France.

Street: 
3-5 impasse Reille
City: 
Paris
Postcode: 
75014
Federal State : 
France
WebSite: 
www.vaxon-biotech.com
Fax: 
33-1-45886780

Company Index Score

Current Index Score Historical Index Score
  • Vaxon Biotech currently scores 50 % in the index.
  • Vaxon Biotech is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Vaxon Biotech is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets